Skip to main content

Neuraxis, INC (NRXS) Stock Forecast 2025 - AI Price Prediction & Analysis


Neuraxis, INC (NRXS) AI Stock Price Forecast & Investment Analysis

Neuraxis, INC Stock Price Chart and Technical Analysis

Loading Neuraxis, INC interactive price chart and technical analysis...

Neuraxis, INC (NRXS) - Comprehensive Stock Analysis & Investment Research

Deep dive into Neuraxis, INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Neuraxis, INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Neuraxis, INC: Neuraxis, INC operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

Neuraxis, INC (Stock Symbol: NRXS) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Neuraxis, INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Neuraxis, INC: With $3M in annual revenue and -362.8% net margin, the company demonstrates developing profitability.

Annual Revenue: $3 million generating a -362.8% net profit margin .

Market Capitalization: $24 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Neuraxis, INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Neuraxis, INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Neuraxis, INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Neuraxis, INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Neuraxis, INC: Market positioning analysis based on available financial and operational metrics.

Neuraxis, INC strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 75.7% gross margin, indicating strong pricing power and operational efficiency.

Neuraxis, INC (NRXS) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Neuraxis, INC stock analysis.

Loading Neuraxis, INC comprehensive fundamental analysis and insider trading data...

Deep dive into Neuraxis, INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Neuraxis, INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Neuraxis, INC: With a P/E ratio of -0.86, the market sees the stock as potentially undervalued.

P/E Ratio -0.86x
P/B Ratio 5.63x
Market Cap $24M
EPS $-1.05
Book Value/Share $0.43
Revenue/Share $0.33
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Neuraxis, INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Neuraxis, INC:

Gross Margin 75.7%
Operating Margin -295.0%
Net Margin -362.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Neuraxis, INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Neuraxis, INC:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Neuraxis, INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Neuraxis, INC:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Neuraxis, INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Neuraxis, INC:

Understanding Financial Statement Data

What these metrics mean: Key figures from Neuraxis, INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Neuraxis, INC: With annual revenue of $3M, Neuraxis, INC represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $3M
R&D Expense $0M
Cost of Goods Sold $0M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 10M
Growth Metrics (YoY)
EPS Growth -86.0%

Latest Neuraxis, INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Neuraxis, INC (NRXS) stock price and investment outlook.

, source: Seeking Alpha

Good day, and thank you for standing by. Welcome to the NeurAxis' Fourth Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' ...

, source: The National Law Review

CARMEL, Ind., May 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...

, source: Barron's

NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending ...

Neuraxis, INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Neuraxis, INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $751M -41.7x 6.7x
BLFS Unlock Forecast - 30 Days FREE Trial $991M -14.7x 2.8x
BSGM Unlock Forecast - 30 Days FREE Trial $126M -1.8x 48.5x
CBLL Unlock Forecast - 30 Days FREE Trial $438M x 2.5x
CNMD Unlock Forecast - 30 Days FREE Trial $1674M 15.2x 1.7x
CUTR Unlock Forecast - 30 Days FREE Trial $9M -0.1x 0.0x
CV Unlock Forecast - 30 Days FREE Trial $0M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.8x
EDAP Unlock Forecast - 30 Days FREE Trial $99M x 2.4x
ELMD Unlock Forecast - 30 Days FREE Trial $218M 28.9x 5.1x
FONR Unlock Forecast - 30 Days FREE Trial $99M 9.5x 0.6x
GTHP Unlock Forecast - 30 Days FREE Trial $22M x x
HSDT Unlock Forecast - 30 Days FREE Trial $66M 0.0x 51.9x
HYPR Unlock Forecast - 30 Days FREE Trial $148M -1.8x 0.9x
INMD Unlock Forecast - 30 Days FREE Trial $1236M x 1.8x
IRIX Unlock Forecast - 30 Days FREE Trial $24M -2.8x 3.9x
IRME Unlock Forecast - 30 Days FREE Trial $1M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3680M 44.5x 2.2x
LIVN Unlock Forecast - 30 Days FREE Trial $3110M -662.0x 2.8x
MASI Unlock Forecast - 30 Days FREE Trial $8006M 128.1x 7.7x
MDT Unlock Forecast - 30 Days FREE Trial $121917M 26.2x 2.6x
MOVE Unlock Forecast - 30 Days FREE Trial $5M -8.6x 0.7x
NDRA Unlock Forecast - 30 Days FREE Trial $2M -0.8x 1.1x
NRXS Unlock Forecast - 30 Days FREE Trial $24M -0.9x 5.6x
NUWE Unlock Forecast - 30 Days FREE Trial $65M -0.1x 18.1x
NXL Unlock Forecast - 30 Days FREE Trial $15M -4.7x 2.4x
NXLIW Unlock Forecast - 30 Days FREE Trial $5M x 1.0x
OM Unlock Forecast - 30 Days FREE Trial $249M -0.4x 1.6x
POCI Unlock Forecast - 30 Days FREE Trial $36M -11.5x 2.8x
QTI Unlock Forecast - 30 Days FREE Trial $7M -0.4x -0.8x
SLNO Unlock Forecast - 30 Days FREE Trial $4417M -18.5x 19.0x
SMLR Unlock Forecast - 30 Days FREE Trial $385M 10.4x 1.0x
STRR Unlock Forecast - 30 Days FREE Trial $7M -1.6x 0.1x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $1182M -8.4x 811.5x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $4337M 60.5x 13.6x
VANI Unlock Forecast - 30 Days FREE Trial $92M -2.7x 7.9x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $46M 41.4x 36.5x

Frequently Asked Questions - Neuraxis, INC Stock Forecast

How accurate are Neuraxis, INC stock predictions?

Our AI model demonstrates 6% historical accuracy for NRXS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Neuraxis, INC stock price forecasts?

Our analysis considers Neuraxis, INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Neuraxis, INC a good investment in 2025?

Based on our AI analysis, Neuraxis, INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Neuraxis, INC forecasts updated?

Neuraxis, INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Neuraxis, INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Neuraxis, INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...